PhRMA: NIH’s Plan To Limit Price Via Licensing Will Chill Collaboration

By Maaisha Osman / August 12, 2024 at 4:23 PM
The drug industry lobby is arguing that the National Institutes of Health’s (NIH) first-ever proposal to use its licensing process to ensure medical products are affordable by keeping U.S. prices equal to those in other developed countries would discourage collaboration between NIH and the private sector. The health research agency published the policy proposal on May 21, and issued a request for information (RFI) from stakeholders on the approach. The drug maker lobby Pharmaceutical Research and Manufacturers of America (PhRMA)...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.